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OBJECTIVE  METHODS 
 
¥  L-BPA is the premier choice in Boron Neutron 
Capture Therapy (BNCT) treating selected head 
and neck tumours.  
 
¥  L-BPA complexed with fructose has low solubility 
(30mg/mL).  Large administration volumes are 
required to dose tens of grams of drug.    
Solutions must be freshly prepared and used 
within 48 hours [1]. 
 
¥  A new improved formulation lyophilised pH8  L-
BPA  solution at 100mg/mL in 110mg/mL 
mannitol [2].  However, the lyophilisation cycle of 
6 days was unfavourable. 
 
¥  The primary objective was to reduce the 
L-BPA in mannitol lyophilisation cycle to 
3 days or less using MTM technology 
¥  MTM software (SMART¨, SP Scientific, Stone Ridge, NY, USA) was operated on an FTS 
Systems Lyostar II drier (Biopharma, Winchester, UK). 
 
¥  Hourly pressure rise data are automatically taken at a rate of 10 samples per second.  The 
system calculates the product temperature at the sublimation interface and mass transfer 
resistance of the product.  Adjustments are then automatically made to the shelf 
temperature and system pressure to achieve a calculated target product temperature.  The 
end of primary drying is determined by comparing the vapour pressure of ice with the 
system chamber pressure [3].  
 
¥  Test vials were 21 x L-BPA at 100mg/mL in 110mg/mL mannitol (Sigma-Aldrich, Poole, UK) 
pH8 filled to 10mL volume in 50mL type 1 clear glass vials (Adelphi Healthcare Packaging, 
Haywards Heath, UK).  Stoppers were 20mm butyl rubber (proved clean) with 20mm tear off 
aluminium overseals (both Adelphi Healthcare Packaging, Haywards Heath, UK).  
 
¥  To examine the run performance, a comparator solution of 5% mannitol in water was used. 
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¥  Applying MTM lyophilisation reduced an original L-BPA drug product drying cycle 
from 6 days to 53 hours.  The test was challenging using a high sold content, high 
fill volume solution in which an L-BPA/mannitol complex is also formed. 
¥  The visual appearance of the cake was poor (shrunken appearance). 
¥  Unsurprisingly, the L-BPA test with 21% w/w solids displayed non-ideal drying 
behaviour.  MTM failed to predict drying parameters, e.g., base of vial temperature, 
that were more closely replicated in the ÔidealÕ 5% mannitol comparator. 
¥  The Tb / Taverage difference may be explained by drying too close to the critical 
temperature, risking cycle failure. 
¥  An increased vial number may improve the feedback information for the MTM 
algorithm.  A reduced test vial number will not suit Ônon-idealÕ formulations. 
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Figure 1. Comparison of drying  
programs for BPA clinical vials [] and those dried 
under SMART¨ MTM []. 
!
Figure 2. Comparison of thermocouple average and 
Tb, the MTM calculated base of vial temperature, 5% 
mannitol test. 
Figure 3. Comparison of thermocouple average  
and Tb, the MTM calculated base  
of vial temperature, L-BPA test. 
